Schisandra chinensis

Schisandra chinensis, known as the five-flavor fruit or Wuweizi, is a medicinal plant used extensively in traditional Chinese medicine and identified as a potent adaptogen. From a pharmacological perspective, it is not a single molecular target (such as a specific protein or receptor) but rather a complex botanical source containing over 40 bioactive dibenzocyclooctadiene lignans, including schisandrin A, B, and C. These constituents exert hepatoprotective and neuroprotective effects by neutralizing reactive oxygen species and modulating signaling pathways like Nrf2 and MAPK. Clinically, Schisandra chinensis is of significant interest due to its impact on drug metabolism. It is a well-documented modulator of the Cytochrome P450 enzyme system, particularly the CYP3A subfamily, which can lead to dangerous increases in the bioavailability of narrow-therapeutic-index drugs such as tacrolimus and cyclosporine. While it shows promise in treating chronic hepatitis and age-related cognitive decline, its use in modern medicine requires careful monitoring of potential drug-drug interactions and patient-specific metabolic profiles (Source: National Center for Complementary and Integrative Health (NCCIH), PubMed, Memorial Sloan Kettering Cancer Center).

Other names

WuweiziFive-flavor fruitChinese Magnolia-vineSchisandra berryMatsubusa

Schisandra chinensis acts as a multi-component pharmacological agent; its primary lignans (e.g., Schisandrin B) activate the Nrf2/ARE antioxidant pathway, inhibit NF-kB-mediated pro-inflammatory cytokine production, and function as potent inhibitors and inducers of Cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) (Source: NIH, PubMed).